Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00520637
Status:
COMPLETED
Last Update Posted:
2009-10-09
First Post:
2007-08-23
Brief Title:
A Phase I Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma EZN-2208-01
Sponsor:
Organization:
Enzon Pharmaceuticals Inc